Literature DB >> 34220749

Effects of Ribosomal Protein S10 Flexible Loop Mutations on Tetracycline and Tigecycline Susceptibility of Escherichia coli.

Norbert Izghirean1,2, Claudia Waidacher1,2, Clemens Kittinger1, Miriam Chyba1,3, Günther Koraimann2, Brigitte Pertschy2,4, Gernot Zarfel1.   

Abstract

Tigecycline is a tetracycline derivative that is being used as an antibiotic of last resort. Both tigecycline and tetracycline bind to the small (30S) ribosomal subunit and inhibit translation. Target mutations leading to resistance to these antibiotics have been identified both in the 16S ribosomal RNA and in ribosomal proteins S3 and S10 (encoded by the rpsJ gene). Several different mutations in the S10 flexible loop tip residue valine 57 (V57) have been observed in tigecycline-resistant Escherichia coli isolates. However, the role of these mutations in E. coli has not yet been characterized in a defined genetic background. In this study, we chromosomally integrated 10 different rpsJ mutations into E. coli, resulting in different exchanges or a deletion of S10 V57, and investigated the effects of the mutations on growth and tigecycline/tetracycline resistance. While one exchange, V57K, decreased the minimal inhibitory concentration (MIC) (Etest) to tetracycline to 0.75 μg/ml (compared to 2 μg/ml in the parent strain) and hence resulted in hypersensitivity to tetracycline, most exchanges, including the ones reported previously in resistant isolates (V57L, V57D, and V57I) resulted in slightly increased MICs to tigecycline and tetracycline. The strongest increase was observed for the V57L mutant, with a MIC (Etest) to tigecycline of 0.5 μg/ml (compared to 0.125 μg/ml in the parent strain) and a MIC to tetracycline of 4.0 μg/ml. Nevertheless, none of these exchanges increased the MIC to the extent observed in previously described clinical tigecycline-resistant isolates. We conclude that, next to S10 mutations, additional mutations are necessary in order to reach high-level tigecycline resistance in E. coli. In addition, our data reveal that mutants carrying S10 V57 exchanges or deletion display growth defects and, in most cases, also thermosensitivity. The defects are particularly strong in the V57 deletion mutant, which is additionally cold-sensitive. We hypothesize that the S10 loop tip residue is critical for the correct functioning of S10. Both the S10 flexible loop and tigecycline are in contact with helix h31 of the 16S rRNA. We speculate that exchanges or deletion of V57 alter the positioning of h31, thereby influencing both tigecycline binding and S10 function.
Copyright © 2021 Izghirean, Waidacher, Kittinger, Chyba, Koraimann, Pertschy and Zarfel.

Entities:  

Keywords:  16S rRNA; helix 31; ribosomal protein S10; rpsJ; tetracycline; tigecycline

Year:  2021        PMID: 34220749      PMCID: PMC8249722          DOI: 10.3389/fmicb.2021.663835

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


  29 in total

1.  Structural and functional analysis of the E. coli NusB-S10 transcription antitermination complex.

Authors:  Xiao Luo; He-Hsuan Hsiao; Mikhail Bubunenko; Gert Weber; Donald L Court; Max E Gottesman; Henning Urlaub; Markus C Wahl
Journal:  Mol Cell       Date:  2008-12-26       Impact factor: 17.970

Review 2.  Assembly of bacterial ribosomes.

Authors:  Zahra Shajani; Michael T Sykes; James R Williamson
Journal:  Annu Rev Biochem       Date:  2011       Impact factor: 23.643

3.  High-level chromosomally mediated tetracycline resistance in Neisseria gonorrhoeae results from a point mutation in the rpsJ gene encoding ribosomal protein S10 in combination with the mtrR and penB resistance determinants.

Authors:  Mei Hu; Sobhan Nandi; Christopher Davies; Robert A Nicholas
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

4.  Genomic analysis of reduced susceptibility to tigecycline in Enterococcus faecium.

Authors:  Vincent Cattoir; Christophe Isnard; Thibaud Cosquer; Arlène Odhiambo; Fiona Bucquet; François Guérin; Jean-Christophe Giard
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

Review 5.  Pharmacokinetic/pharmacodynamic profile for tigecycline-a new glycylcycline antimicrobial agent.

Authors:  Alison K Meagher; Paul G Ambrose; Thaddeus H Grasela; Evelyn J Ellis-Grosse
Journal:  Diagn Microbiol Infect Dis       Date:  2005-07       Impact factor: 2.803

6.  Adaptive laboratory evolution of Vibrio cholerae to doxycycline associated with spontaneous mutation.

Authors:  Lekshmi Narendrakumar; Sivakumar Krishnankutty Chandrika; Sabu Thomas
Journal:  Int J Antimicrob Agents       Date:  2020-07-19       Impact factor: 5.283

7.  Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA.

Authors:  Gesine Bauer; Christian Berens; Steven J Projan; Wolfgang Hillen
Journal:  J Antimicrob Chemother       Date:  2004-02-25       Impact factor: 5.790

8.  Discovery of a small molecule that inhibits bacterial ribosome biogenesis.

Authors:  Jonathan M Stokes; Joseph H Davis; Chand S Mangat; James R Williamson; Eric D Brown
Journal:  Elife       Date:  2014-09-18       Impact factor: 8.140

9.  Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ.

Authors:  Li Fang; Qiong Chen; Keren Shi; Xi Li; Qiucheng Shi; Fang He; Jiancang Zhou; Yunsong Yu; Xiaoting Hua
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

10.  CusS-CusR Two-Component System Mediates Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Dongjie Chen; Yunan Zhao; Yanqin Qiu; Liying Xiao; Huaqiang He; Dongmei Zheng; Xiaoqin Li; Xiaoli Yu; Nengluan Xu; Xinlan Hu; Falin Chen; Hongru Li; Yusheng Chen
Journal:  Front Microbiol       Date:  2020-01-28       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.